Bioactivity:

BDP9066 has therapeutic effect on skin cancer by reducing substrate phosphorylation. BDP9066 is a potent and selective myotonic dystrophy-related Cdc42-binding kinase MRCK inhibitor. With an IC50 of 64 nM for MRCK_ in SCC12 cells, Ki values of 0.0136 nM a

CAS nr:

2226507-04-4

Purity:

98%

Molecular Weight:

348,44

SMILES:

C12=C(N3CCC[C@@]4(CCCCN4)C3)C=CNC1=NC=C2C5=NC=NC=C5

Formula:

C20H24N6

Pathway:

Others

Target:

Others